Cargando…
Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
Ovarian cancer is the 5th most common cancer in UK women with a high relapse rate. The overall survival for ovarian cancer has remained low for decades prompting a real need for new therapies. Recurrent ovarian cancer remains confined in the peritoneal cavity in >80% of the patients, providing an...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726300/ https://www.ncbi.nlm.nih.gov/pubmed/31595233 http://dx.doi.org/10.1016/j.pbj.0000000000000007 |